Relative contribution of three main virulence factors in Pseudomonas aeruginosa pneumonia*

Objective:The pathogenesis and the outcome of Pseudomonas aeruginosa ventilator-acquired pneumonia depend on the virulence factors displayed by the bacteria as well as the host response. Thus, quorum sensing, lipopolysaccharide, and type 3 secretion system have each individually been shown to be important virulence systems in laboratory reference strains. However, the relative contribution of these three factors to the in vivo pathogenicity of clinically relevant strains has never been studied. We analyzed the virulence of 56 nonclonal Pseudomonas aeruginosa strains isolated from critically ill patients with ventilator-acquired pneumonia. To avoid the variation of human immune response, we used a murine model of pneumonia. The aim was to determine which virulence factor was the most important. Setting:Research laboratory of a university. Subjects:Male adult BALB/c mice. Interventions:In vitro, the phenotype of each strain was established as to the expression of quorum sensing-regulated factors (elastase and pyocyanin), type 3 secretion system exotoxin secretion (Exotoxin U, S and/or T, or “nonsecreting”), and lipopolysaccharide O-antigen serotype. Strain pathogenicity was evaluated in vivo in a mouse model of acute pneumonia through lung injury assessment by measuring alveolar–capillary barrier permeability to proteins, lung wet/dry weight ratio, and bacterial dissemination. Associations were then sought between virulence system phenotypes and levels of lung injury. Measurements and Main Results:In univariate analysis, elastase production, O11 serotype, and type 3 secretion system exotoxin secretion were associated with increased lung injury and exotoxin U was linked to an increase risk of bacteremia. In multivariate analysis, we observed that type 3 secretion system exotoxin secretion and to a lesser degree elastase production were associated with increased lung injury. Conclusion:In a murine model of pneumonia, our data suggest that type 3 secretion system and elastase are the most important virulence factors in clinically relevant P. aeruginosa strains.

[1]  J. Rello,et al.  Pseudomonas aeruginosa virulence and therapy: Evolving translational strategies* , 2009, Critical care medicine.

[2]  J. Engel,et al.  Role of Pseudomonas aeruginosa type III effectors in disease. , 2009, Current opinion in microbiology.

[3]  S. Lynch,et al.  Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia. , 2008, American journal of respiratory and critical care medicine.

[4]  K. Faure,et al.  Quorum-sensing activity and related virulence factor expression in clinically pathogenic isolates of Pseudomonas aeruginosa. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  J. Musser,et al.  Secreted bacterial phospholipase A2 enzymes: better living through phospholipolysis. , 2007, Trends in microbiology.

[6]  S. Lynch,et al.  Presence or Absence of Lipopolysaccharide O Antigens Affects Type III Secretion by Pseudomonas aeruginosa , 2007, Journal of bacteriology.

[7]  T. Kirikae,et al.  Outbreaks of Multidrug-Resistant Pseudomonas aeruginosa in Community Hospitals in Japan , 2006, Journal of Clinical Microbiology.

[8]  P. Gosset,et al.  Alveolar Response to Pseudomonas aeruginosa: Role of the Type III Secretion System , 2005, Infection and Immunity.

[9]  A. Filloux,et al.  Quorum Sensing Negatively Controls Type III Secretion Regulon Expression in Pseudomonas aeruginosa PAO1 , 2005, Journal of bacteriology.

[10]  A. Prince,et al.  Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. , 2005, American journal of respiratory and critical care medicine.

[11]  J. Mekalanos,et al.  Role of the Type III Secreted Exoenzymes S, T, and Y in Systemic Spread of Pseudomonas aeruginosa PAO1 In Vivo , 2005, Infection and Immunity.

[12]  J. Costerton,et al.  Can laboratory reference strains mirror "real-world" pathogenesis? , 2005, Trends in microbiology.

[13]  D. Hassett,et al.  The role of pyocyanin in Pseudomonas aeruginosa infection. , 2004, Trends in molecular medicine.

[14]  A. Hauser,et al.  Relative Contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to Virulence in the Lung , 2004, Infection and Immunity.

[15]  D. Hassett,et al.  Pseudomonas aeruginosa Pyocyanin Is Critical for Lung Infection in Mice , 2004, Infection and Immunity.

[16]  J. Sun,et al.  Pseudomonas aeruginosa ExoS and ExoT. , 2004, Reviews of physiology, biochemistry and pharmacology.

[17]  J. Rello,et al.  Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia. , 2003, The Journal of infectious diseases.

[18]  F. Roudot-thoraval,et al.  Role of the quorum-sensing system in experimental pneumonia due to Pseudomonas aeruginosa in rats. , 2003, American journal of respiratory and critical care medicine.

[19]  David Shimabukuro,et al.  O-Antigen Serotypes and Type III Secretory Toxins in Clinical Isolates of Pseudomonas aeruginosa , 2003, Journal of Clinical Microbiology.

[20]  J. Alcorn,et al.  Pseudomonas aeruginosa elastase degrades surfactant proteins A and D. , 2003, American journal of respiratory cell and molecular biology.

[21]  J. Rello,et al.  Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by Pseudomonas aeruginosa. , 2002, Critical care medicine.

[22]  A. Hauser,et al.  Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa. , 2001, Microbiology.

[23]  R. Savel,et al.  Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. , 2001, The Journal of infectious diseases.

[24]  A. Prince,et al.  Pseudomonas aeruginosa Cell-to-Cell Signaling Is Required for Virulence in a Model of Acute Pulmonary Infection , 2000, Infection and Immunity.

[25]  G. Pier,et al.  Acquisition of Expression of the Pseudomonas aeruginosa ExoU Cytotoxin Leads to Increased Bacterial Virulence in a Murine Model of Acute Pneumonia and Systemic Spread , 2000, Infection and Immunity.

[26]  K. M. Lee,et al.  Identification of genes controlled by quorum sensing in Pseudomonas aeruginosa. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  B. Toussaint,et al.  Cell Death of Human Polymorphonuclear Neutrophils Induced by a Pseudomonas aeruginosa Cystic Fibrosis Isolate Requires a Functional Type III Secretion System , 1999, Infection and Immunity.

[28]  T. Martin,et al.  Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia. , 1999, The Journal of clinical investigation.

[29]  L. Burrows,et al.  Genetics of O-Antigen Biosynthesis inPseudomonas aeruginosa , 1999, Microbiology and Molecular Biology Reviews.

[30]  F. Gejyo,et al.  The role of Pseudomonas aeruginosa elastase as a potent inflammatory factor in a rat air pouch inflammation model. , 1999, FEMS immunology and medical microbiology.

[31]  J. Wiener-Kronish,et al.  Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury , 1999, Nature Medicine.

[32]  J. Barbieri,et al.  ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  C. Hueck,et al.  Type III Protein Secretion Systems in Bacterial Pathogens of Animals and Plants , 1998, Microbiology and Molecular Biology Reviews.

[34]  E. Ujack,et al.  Pseudomonas aeruginosa lasRTranscription Correlates with the Transcription of lasA,lasB, and toxA in Chronic Lung Infections Associated with Cystic Fibrosis , 1998, Infection and Immunity.

[35]  J. Engel,et al.  PepA, a secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence , 1998, Molecular microbiology.

[36]  D. Corry,et al.  IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. , 1997, Journal of immunology.

[37]  Lei Zhu,et al.  ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury , 1997, Molecular microbiology.

[38]  P. Seed,et al.  Regulation of las and rhl quorum sensing in Pseudomonas aeruginosa , 1997, Journal of bacteriology.

[39]  A. Azghani.  Pseudomonas aeruginosa and epithelial permeability: role of virulence factors elastase and exotoxin A. , 1996, American journal of respiratory cell and molecular biology.

[40]  R. Wunderink,et al.  Ventilator-associated pneumonia due to Pseudomonas aeruginosa. , 1996, Chest.

[41]  J. Barbieri,et al.  Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa , 1996, Journal of bacteriology.

[42]  D. Ohman,et al.  Synthesis of multiple exoproducts in Pseudomonas aeruginosa is under the control of RhlR-RhlI, another set of regulators in strain PAO1 with homology to the autoinducer-responsive LuxR-LuxI family , 1995, Journal of bacteriology.

[43]  T. Yahr,et al.  Transcriptional analysis of the Pseudomonas aeruginosa exoenzyme S structural gene , 1995, Journal of bacteriology.

[44]  J. Pittet,et al.  Exoproduct secretions of Pseudomonas aeruginosa strains influence severity of alveolar epithelial injury. , 1994, The American journal of physiology.

[45]  J. Pittet,et al.  Alveolar epithelial injury and pleural empyema in acute P. aeruginosa pneumonia in anesthetized rabbits. , 1993, Journal of applied physiology.

[46]  P. Montravers,et al.  Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. , 1993, The American journal of medicine.

[47]  M. Matthay,et al.  Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. , 1991, The Journal of clinical investigation.

[48]  M. Gambello,et al.  Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transcriptional activator of elastase expression , 1991, Journal of bacteriology.

[49]  R. Sorensen,et al.  Biological effects of Pseudomonas aeruginosa phenazine pigments. , 1987, Antibiotics and chemotherapy.

[50]  C. Bryan,et al.  Bacteremic nosocomial pneumonia. Analysis of 172 episodes from a single metropolitan area. , 2015, The American review of respiratory disease.

[51]  T. Pitt,et al.  Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa , 1984, Infection and immunity.

[52]  J. Pennington,et al.  Evaluation of Pseudomonas aeruginosa exotoxin A and elastase as virulence factors in acute lung infection , 1983, Infection and immunity.

[53]  S. Cryz,et al.  Isolation and characterization of Pseudomonas aeruginosa PAO mutant that produces altered elastase , 1980, Journal of bacteriology.